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Absence of cystic fibrosis mutations in a large
Asian population sample and occurrence of a
homozygous S549N mutation in an inbred
Pakistani family
Ann Curtis, R J Richardson, J Boohene, A Jackson, R Nelson, S S Bhattacharya
Abstract
The occurrence of cystic fibrosis is very
rare in the Asian population. Carriers of
the mutations most commonly found in
Caucasians were not detected in a large
Asian population sample of almost 900
chromosomes. However, an affected Pak-
istani child born to consanguineous par-
ents was further investigated and shown
to be homozygous for the mutation
S549N (G-8A). Molecular and clinical
data are presented which may improve
our understanding of the phenotypic
effects of the S549N mutation in the
CFTR gene.
(J Med Genet 1993;30:164-6)
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Cystic fibrosis (CF) is reported to be one of the
most common severe recessive disorders in the
Caucasian population.' The carrier frequency
among Caucasians averages about 1/25.
A mutation has been identified in the CF
gene whose frequency increases in a south-east
to north-west gradient from 30% in Turkey to
87% in Denmark.2 The mutation is a deletion
of CTT in exon 10 which results in the re-
moval of a phenylalanine residue at amino acid
position 508 (A F508) in the encoded protein,
the CF transmembrane conductance regulator
(CFTR).3
The number of further mutations which
have been identified in the CF gene is now
about 200. However, there are a cluster of
mutations in exon 11 which account for a
further 4 to 5% of the defective Caucasian CF
chromosomes.'5
The disease incidence of CF in other ethnic
groups is very low, for example 1/10000 in
Pakistanis in England, 1/17000 in blacks in
Washington, and 1/90 000 in orientals in Ha-
waii,' and there are fewer than 10 confirmed
cases of CF in African blacks.6 Devoto et al7
found no A F508 carriers among an unrelated
sample of 98 Chinese, 50 Dravidian Indians,
68 Malaysians, and 85 black Africans from
Zimbabwe. However, these authors did not
exclude possible occurrence of other CF muta-
tions in these populations in view of the
increasing molecular heterogeneity of CF and
the gradient distribution of A F508 in Europe.
In this study, we have analysed 443 unaffec-
ted Asians (400 unrelated Indians, 43 unre-
lated orientals) and 222 unrelated Caucasians
from north-east England for the presence of
exon 10 A F508 mutations and 200 members
of the same Asian sample for the exon 11
mutations G551D, R553X, and S549.4 In ad-
dition, we have identified a Pakistani child
with CF with consanguineous parents who is
homozygous for the exon 11 mutation R549N.
Owing to the rare occurrence of most of the
non- A F508 mutations, correlations between
the variable CF phenotype and genotype have
been difficult to catalogue. Some non- A F508
compound heterozygotes have been
reported,89 but their small numbers make
meaningful analysis difficult. The functions of
the several domains of the CFTR protein may
be better understood from a study of the
phenotypes of subjects who are shown to be
homozygous for rare mutations when it may be
simpler to assess the pulmonary and gastric
contributions of the various mutations. Such
homozygotes are likely to be extremely rare,
but some useful cases have been identified,
such as a G85E homozygotel' and an R553X"
homozygote, in addition to the S549N case
described here. Significantly all three of these
patients were born to consanguineous parents.
Materials and methods
SAMPLES
DNA was extracted by standard methods from
10 ml frozen blood samples from the parents
and three children of a Pakistani family, of
which one child was affected with CF, and
from 400 unrelated Indians, collected at a
blood transfusion centre in Bombay, from 43
unrelated orientals, and from 222 unrelated
Caucasians living in the north-east of England.
CASE REPORT
The proband was born by caesarean section at
term, birth weight 3118 g. She presented with
chronic cough and failure to thrive at the age of
4 months. Stools were offensive and contained
numerous fat globules on microscopy. Serum
immune reactive trypsin was increased, and
sweat tests were diagnostic of cystic fibrosis
(sweat sodium 85 pmol/l, sweat chloride 85
and 95 iimol/l).
She continued to have a poor appetite and
poor growth and weight gain, despite efforts to
supplement her calorie intake as an outpatient
and inpatient. Current height and weight are
below the 3rd centile. Chronic progressive
chest infections have continued despite many
courses of antibiotics. Her lungs have been
infected by mucoid strains of Pseudomonas
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aeruginosa since the age of 5 years. Pulmonary
function test (FVC, FEVI, and PEFR) are
reduced to less than 50% expected values for
her height and age. She has had several minor
haemoptyses and chest x rays show progressive
changes of hyperinflation and bronchiectasis of
both bases.
DETECTION OF MUTATIONS
Exon 10 and exon 11 of the CF gene were
amplified through 30 cycles of the polymerase
chain reaction (91'C for 30 seconds, 520 for 30
seconds, 72'C for one minute) in reaction
mixes containing 0.5 pmol/l of each exonic
primer.
Exon lOF: GTTTTCCTGGATTATGCCTGGCAC.
Exon lOR: GTTGGCATGCTTTGATGACGCTTC.
Exon lF: AGACATCTCCAAGTTTGCACA.
Exon 1 lR: CTTGCTAAAGAAATTCTTGC.
Heterozygotes for the A F508 mutation
were identified after electrophoresis of the
exon 10 PCR products on 10% neutral polyac-
rylamide gels when heteroduplex bands were
clearly visible after ethidium bromide staining.
The S549 mutation was detected by the
removal of a DdeI site and G551D and R553X
mutations were identified by the creation of an
MboI site and the removal of a HinclI site
respectively in the exon 11 PCR product.
DNA SEQUENCING
PCR products for sequencing were prepared
in reaction mixes containing one 5' biotinylated
primer and one normal primer. The double
stranded product was denatured in 0-15 mol/l
NaOH and the biotinylated strand was separ-
ated from the non-biotinylated strand using
magnetic streptavidin coated beads (Dyna-
beads, Dynal UK Ltd). The biotinylated
strand was sequenced from the original non-
biotinylated PCR primer by the dideoxy chain
formation method using a USB sequenase ver-
sion 2 0 DNA sequencing kit and 35S dATP as
the radioactive label.
Results
Thirteen CF heterozygotes (5 8%) were
detected among the 222 unrelated Caucasians
from the north-east of England. Eleven of
these carried the A F508 mutations and two
had the G551D mutation. None of the unaf-
fected Asian samples tested (400 unrelated
Indians, 43 unrelated orientals) were AF508,
G551D, R553X, or S549 carriers.
The five members of the Pakistani family
tested negative for the AF508, G551D and
R553X mutations, but the affected child
appeared homozygous for the rare exon 11
S549 mutation when the PCR product failed to
digest with DdeI. This was confirmed when
both parents were shown to be S549 heterozy-
gotes as presented in fig 1. The exon 11 PCR
products from both of her unaffected brothers,
however, digested completely with DdeI.
Sequencing results of PCR products from the
mother, the affected child, and one unaffected
child are shown in fig 2. These show a G to A
substitution at cDNA nucleotide position 1778
which creates the S549N (Ser-+Asn) mutation
in the CFTR protein previously described by
Cutting et al.4
Discussion
Cystic fibrosis has rarely been described in
subjects from the Asian population. No car-
riers of the commonest Caucasian CF muta-
tion (AF508) or of the less common G551D,
R553X, and S549N mutations were detected
in an Asian population of 443 unrelated sub-
jects, even though the frequency of 5-8% in
our population was slightly greater than
expected. However, the presence of other CF
mutations cannot be excluded when the
emerging molecular heterogeneity of CF is
considered.
Schwartz et all2 reported six affected Pakis-
tani children, all with consanguineous parents,
of whom three were homozygous for A F508
and three had unidentified mutations. The
affected Pakistani child studied here is homo-
zygous for a rare CF mutation, S549N. Homo-
zygosity is not unexpected considering the
close relationship of her parents. The detec-
tion of this mutation allowed carrier testing for
her two unaffected brothers, neither of whom
were shown to carry the S549N mutation (figs
1 and 2).
Some 80 to 85% of CF patients have the
severe pancreatic insufficient form of the dis-
ease. If these patients are homozygous for
'severe' alleles which are recessive to the puta-
tive 'milder' alleles associated with pancreatic
sufficiency, then the frequency of severe alleles
must be 90 to 92%. However, compound
±
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Figure 1 Lanes 1, 3, 5, 7, and 9 show the 95 bp
undigested CFTR exon 11 PCR product. Lanes 2, 4, 6,
8, and 10 show the PCR product after DdeI digestion
which produces fragments of 58 bp and 37 bp. The lanes
correspond to the subjects shown in the pedigree directly
above. Both parents are heterozygous for the presence of
the DdeI restriction site, both unaffected sons are
homozygous for the presence of the site, and the affected
daughter is homozygous for absence of the site.
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Figure 2 Sequence of CFTR nucleotides 1771-1784 showing the sut
an A residue (indicated by the dots) at position 1778 in the carrier
removes a DdeI restriction site and mutates the amino acid position
substitution has been inherited by the affected girl in the homozygou
her normal brother.
heterozygotes may present a e
picture and, therefore, homo:
more informative for determin
cal effects of different mutat
possible that the absence of a
altogether, as in the homo
patient,'1 may be less severe tha
or deletion mutation, since cc
of CFTR may be more comp
function than an altered men
Exon 11 mutations affect the
binding fold of CFTR and thu,
expected to have a severe ph
The mutations S5491 (Ser-*]
(Ser-*Arg) have been report
The homozygous S549N (Ser-*Asn) child de-
scribed here shows a severe clinical course
with malnutrition, growth failure, and ad-
vanced pulmonary disease, despite diagnosis
during early infancy, aggressive treatment of
the pancreatic steatorrhoea and chest infec-
tion, and calorie supplements.
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